Introduction: Diabetic retinal complications are the most common cause of reduced visual acuity in persons aged 25 to 75 years. However, vision loss can be prevented or delayed if the changes are seen on time. Aim: By analyzing literature data to create an algorithm for careful follow-up of diabetic patients, which would prevent progression of the changes and development of conditions leading to blindness. At the same time, this paper presents certain changes of the eye fundus and mode of their treatment. Material and method: Analysis of studies published on diabetic retinopathy and screening conducted in developed countries, with creating an algorithm for follow-up of diabetic retinal changes and their management. Conclusion: Timely detection and treatment of diabetic retinopathy with application of protocols in developed countries as well as parallel correction of systemic risk factors for progression of diabetic retinopathy will reduce the possibility of visual impairment in diabetics due to retinal complications. At the same time expenditures related to more complicated and less effective surgical procedures will be reduced along with the societal concern.
Diabetes mellitus is a multifactorial, heterogenic, metabolic disorder characterized by chronic hyperglycemia and disturbances of carbohydrate, fat and protein metabolism as a result of defects in insulin secretion, insulin action or both [1] .
Dysmetabolic syndrome present in diabetes mellitus causes blood vessels pathologic alterations, primarily in retinal microvasculature, resulting in damage of all organs of the human body with consequent disability. Late complications in diabetes mellitus include macrovascular (atherosclerosis and cardiovascular disease, cerebrovascular disease and disease of peripheral blood vessels) and microvascular (diabetic nephropathy, neuropathy and diabetic retinopathy) [2] . It is a well-known fact that perception of the external world is done through eyes in almost 80%, and thus the importance of diabetic retinopathy is evident as one of the late complications in diabetic patients.
According to the Health Intelligence an estimated 382 million people had diabetes in 2013 and by 2030 this number is estimated to almost double, is a significant number [3] . At the same time diabetic retinal complications are the most common cause of reduced visual acuity in persons aged 25 to 75 years, that is, in the working-age and productive population. These facts about the nature of the disease and its incidence portray the implications not only on the personal health but on socio-economic status of the country, as well.
The large interest for the disease has been at the same time a provocation to conduct a large number of studies worldwide, some of them being collaborative, multicentered and long-lasting. The aim of these studies has been to resolve many unknown issues and they have presented knowledge on the development of diabetic retinopathy, risk factors and treatment of patients. Table 1 gives a list of some of the conducted studies. 
Levels of diabetic retinopathy

Non-proliferative retinopathy
Mild -presence of at least one aneurysmal dilation, but hemorrhage or aneurysms are less present than in the ETDRS standard photography 2A (Airlie House Classification) in all 4 retinal quadrants (Fig. 1) . Moderate -hemorrhage or aneurysms are more present than in the ETDRS standard photography 2A in at least one quadrant, but in less than 4 retinal quadrants. Cotton wool, IRMA, venous beading are present to a smaller extent (Fig. 2) Severe -hemorrhage and aneurysms in each of 4 quadrants, venous beading in at least two quadrants and IRMA in at least one quadrant. Very severe -two or several characteristics of the lesions found in the severe non-proliferative retinopathy, but not clear neovascularization. Proliferative retinopathy (PDR) is characterized by neovascularization (NV) in the retina or optic disc (Fig. 3) . Early proliferative -characterized by new blood vessels with retinal changes that have characteristics of severe or very severe NDR. High-risk PDR is characterized with:
-Neovascularization of the optic nerve within -1/3 of disc area, that is, neovascularization equal or larger than NVD in standard photograph 10A; -NV smaller than ¼ of PNO, but present retinal or vitreous hemorrhage; -NV larger or equal to ½ PNO, with new vitreous hemorrhage. Advanced PDR High-risk PDR with traction ablation that involves m. lutea or there is hemorrhage, which does not allow to see or grade NVD and NVE (WESDR 1984 (WESDR -1994 (Fig. 4) . Studies have shown that adequate treatment, that is application of scatter panretinal Laser Photocoagulation (LFC), reduces the risk of vision loss within 5 years in patients whose stage of retinopathy is advancing to high-risk proliferative retinopathy of 5% (which usually amounts to 60%) while in patients with Clinically Significant Macular Oedema (CSMO) it reduces the risk of moderate vision loss from 50% to 12%, and even to a smaller percentage if focal LFC to macula is applied [4] .
Understanding the mechanisms, risk factors for development of vascular changes and their characteristics have yielded classification of stages of diabetic retinopathy. The percentage of progression from the current stage to the advanced stage within one year as well as progression to high-risk proliferative retinopathy has also been demonstrated. (1991) scale that incorporates grading of diabetic retinopathy established by Airlie House classification, which has been made to serve the aims of the study. Retinopathy is generally divided into proliferative and non-proliferative [4, 5] . Maculopathy is a separate entity of diabetic retinal impairment and it can occur in all stages of diabetic retinopathy (Fig. 5) . It can be manifested as retinal edema (seen as retinal thickening within 2 disc diameters -2 DD of the center of the macula). Edema that involves the center of the macula should be treated and is separately denoted as a clinically significant macular edema (CSME; ETDRS). Besides edema, during development of diabetic retinal changes macula might suffer as a result of non-perfusion, traction in macula with fibrous tissue, lamellar or entire macular hole [4] . Studies have also reported a very important issue related to degree of retinal changes progression indicating the timing of patient's follow-up. In fact, the following has been demonstrated:
-Mild: the risk of progression from non Proliferative Diabetic Retinopathy (NDR) to Proliferative Diabetic Retiniopathy (PDR) within one year is 5% while the risk of progression to high-risk PDR within five years amounts to 15%.
-Moderate: the risk of progression to PDR within one year is 12-27% while in highrisk PDE within 5 years it amounts to 33%.
-Severe: the risk of progression to PDR within one year is 52% while in high-risk PDR within 5 years it amounts to 60%.
-Very severe: the risk of developing proliferative retinopathy within one year is 75%.
As a result of the assessment of the risk progression ETDRS study proposed careful follow-up and advice for LFC treatment.
-Control of patients with mild or moderate diabetic retinopathy is advised at 6-12 months;
-Control of patients with severe diabetic retinopathy is advised at 2-4 months;
-Control of patients with very severe diabetic retinopathy is advised at 2-3 months;
-In case of CSME in any form of retinopathy focal treatment of macula is recommended.
Macular edema might be treated with some new modules, such as intravitreous application of corticosteroids, anti Vascular Endothelial Growth Factor (anti-VEGF), or vitrectomy.
Immediate scatter panretinal photocoagulation is recommended both in early proliferative retinopathy and in high-risk diabetic retinopathy. Depending on the risk assessment made by the ophthalmologist scatter panretinal photocoagulation might be applied in severe and very severe retinopathy [5, 6] .
Diabetic retinopathy is a complication with a progressive course leading to vision loss, but however, it has to be stressed that diabetic retinopathy is a condition in which vision loss can be prevented or delayed if changes are timely detected and adequate treatment is provided.
Initial ophthalmological approach and timing of examination in diabetic patients
Since diabetic retinopathy is very often asymptomatic and hence suitable to be treated, systemic ophthalmic examinations are essential to ensure early detection.
Important issues in diabetic patients! When establishing the diagnosis of the disease (diabetes mellitus) it should take:
-Comprehensive ophthalmic examination, -standard fundus photography (camera of 30-degrees) through dilated pupils and analyses of images.
Being aware of the seriousness of this problem there is a screening program for diabetic retinopathy in developed countries. This screening includes ophthalmologic examination of diabetic patients by employing standard stereoscopic fundus photographic technique (with camera of 30-degrees) through dilated pupils and analyses of images by ophthalmologists -specialists in this field. It is under discussion whether one fundus image taken with camera of 45-degrees is valid for detecting the existence and grade of diabetic retinopathy. However, since the number of diabetic population is increasing, by calculating the costs, time for screening and competent staff, studies accomplished in developed countries have balanced the efficacy of the screening and the expenditures.
Concerning economic efficacy, the study conducted by British researchers [7] has shown that only 30% of type 2 diabetic patients are likely to develop some degree of diabetic retinopathy over time. Consequently, the anticipated annual examination in patients at no other risks might not be cost-effective. The mentioned study comprised 7600 patients with type 2 diabetes and analyzed the results of the annual eye examinations. The percentage of potentially sight-threatening disease ranged from 0.3% in patients with no initial evidence of retinopathy in the first year to 15% in patients with moderate diabetic retinopathy at their first examination of establishing the diagnosis.
In line with the conclusions of the study a regular ophthalmic examination has been recommended in diabetic patients who showed no signs of retinopathy at the initial examination. Annual ophthalmic examination has been advised to patients who started insulin treatment for diabetes or who have had the disease for more than 20 years or who have had sings of a background retinopathy. In case of mild retinopathy at initial examination follow-up is advised at each 4 months [7] .
Respecting the recommendations of the previous studies, first of all of ETDRS, and based on clinical evidence presented in recent studies, together with the conclusions of American Diabetes Assotiation (ADA) and American Academy of Ophthalmology ( AAO) [8, 9, 10, 11, 14] , National Health and Medical Research Council (NHMRC) [18] , National Guideline Clearinghouse [13], NHS (National Health Screening) program [15, 16] , etc. the following has to be remembered and it is sublimed in the presented algorithm of the Module 10 of Type 2 Diabetes Mellitus within Hong Kong Reference Framework for Diabetes Care for Adults [17, 18] .
Algorithm of ophthalmological follow-up in diabetic patients MODULE 10 (Hong Kong Reference Framework for Diabetes Care for Adults)
Appropriate follow-up care of the eyes: 1. Immediately upon detection of DM, it is necessary to make examination through dilated pupils and determine visual acuity, clouding of the eye's lens and onset of retinopathy;
2. Fundus photography; 3. Follow-up: once per year. In case of one or several normal findings the follow-up is advised at 2-3 years.
Examination of diabetic patients with risk factors.
Control examinations are to be made more frequently if there is a background retinopathy in patients with the following risk factors:
-Poor glycemic control (HbA1c > 8%); -Poor blood pressure control; -Sudden reduction of visual acuity; -Duration of diabetes for more than 10 years;
-Microalbuminuria and proteinuria; -Hyperlipidemia; -Pregnancy. 4. When planning pregnancy, a comprehensive eye examination and counseling on the risk of development and progression of DR is recommended. During pregnancy eye examinations are to be made in the first trimester and possibly again throughout pregnancy and one year postpartum.
Need for referral to tertiary ophthalmological institution A DM patient who has been found to have macular edema, pre-proliferative or proliferative retinopathy is referred to an experienced ophthalmologist, who is an expert in treatment of diabetic retinopathy.
In all cases of DM with the following conditions:
-Pregnancy; -Proliferative or pre-proliferative retinopathy;
-Severe non-proliferative retinopathy that is sudden and progressive; -Macular edema; -Unexplained visual impairment. In type 1 DM the first control is recommended at 3-5 years after diagnosis of the disease and consequently at 1 year. Evaluation for diabetic retinopathy is not necessary in children aged 10-11 years. During puberty a closer monitoring is recommended [9] .
Diabetic retinal complications are still an important and current problem, which has been confirmed by the latest research implying the complexity of the retinal damage mechanisms [19, 20, 21] . However, development and application of new imaging technologies and new therapeutic modalities [22, 23, 24] offered new possibilities for treatment of retinal complications.
Vitreous surgery is reserved for more severe cases of diabetic retinopathy. However, early detection of retinal diabetic complications and their treatment will prevent and delay development of retinal complications, especially development of an advanced stage of diabetic retinopathy that cannot be managed and can lead to eye pain due to development of neovascular glaucoma. These conditions are to be recognized by the ophthalmologists if they comply with the principles of detection and treatment of diabetic retinal complications (Fig. 6) . 
Conclusion
Timely detection and treatment of diabetic retinopathy with application of protocols in developed countries as well as parallel correction of systemic risk factors for progression of diabetic retinopathy will reduce the possibility of visual impairment in diabetic patients due to retinal complications. At the same time expenditures related to more complicated and less effective surgical procedures will be reduced along with societal concern.
